blepharoconjunctivitis


Also found in: Dictionary, Thesaurus, Medical.

blepharoconjunctivitis

[¦blef·ə·rō·kən‚jəŋk·tə′vīd·əs]
(medicine)
Inflammation of the eyelids and the conjunctiva.
References in periodicals archive ?
In a 10-year, single-center review of 338 patients on long-term topical therapy for atopic blepharoconjunctivitis with either tacrolimus (Protopic), pimecrolimus 1% cream (Elidel), or topical corticosteroids, tacrolirnus displayed the best efficacy and tolerability, according to Dr.
Many of these conditions can be managed by optometrists, especially those with AS and IP qualifications, and can include more complex cases of blepharitis and blepharoconjunctivitis, limbal and peripheral corneal infiltrates and non-perforating abrasions and foreign bodies.
At the upcoming ARVO Annual Meeting, InSite researchers will present data from a prior Phase 3 clinical study in patients with blepharoconjunctivitis supporting DexaSite's efficacy and safety.
Logically, a bacterial blepharoconjunctivitis or conjunctivitis will develop as and when the levels of bacteria exceed the protective functions of the tear film and the capacity of the tear film drainage to remove bacteria from the ocular surface.
The next near-term product opportunity in InSite's pipeline is ISV-502 (AzaSite Plus[TM]), a topical combination antibiotic/corticosteroid product for the treatment of blepharoconjunctivitis (also known as lid margin disease), a condition that currently has no approved therapy.
InSite Vision Incorporated (AMEX:ISV) today announced preliminary results from the company's Phase 3a clinical trial of ISV-502 (AzaSite Plus[TM]) a topical combination antibiotic/corticosteroid product for the treatment of blepharoconjunctivitis.
ISV-502 is targeted at meeting this unmet need by conveniently treating both the infection and inflammation associated with blepharoconjunctivitis with one easy-to-use product.
InSite announced today that enrollment is ahead of schedule and is more than 85% complete for its first Phase 3 pivotal clinical trial of ISV-502 under development for the treatment of blepharoconjunctivitis.